How to Qualify Kojic Dipalmitate Before Comparing 98% and 99% Offers

Quick Answer

Do not choose kojic dipalmitate only because a marketplace listing says 98% or 99%. First confirm that the product identity, CAS number, molecular formula, assay method, physical form, sample and batch COA all describe the same material. For this esterified brightening ingredient, the difference between a useful offer and a difficult one is often hidden in the analytical definition, not in the headline percentage.

Start with the Identity, Not the Claim

Kojic Dipalmitate is also called Kojic Acid Dipalmitate or Kojic Acid Palmitate in commercial listings. PubChem records the substance under CAS 79725-98-7 and gives the molecular formula C38H66O6. TCI lists the same CAS, formula and a molecular weight of 618.94. These are useful reference points for the RFQ, but they do not prove that every marketplace listing using the same CAS contains the same grade.[1,2]

The first task is to separate three things that are often blended together in supplier language: a defined raw material, a branded cosmetic active and a finished formula. A defined powder should identify the neat material and its test basis. A branded active may contain a carrier or have an active-equivalent percentage. A finished emulsion or serum study may support a formulation concept, but it is not a substitute for raw-material identity evidence.

Use one controlled description in your purchasing file: Kojic Dipalmitate, CAS 79725-98-7, defined cosmetic raw material, with no undisclosed carrier. If the supplier cannot accept that description, ask what exactly is being quoted before comparing prices.

Why 99% Is Not a Complete Specification

99% is meaningful only when the supplier defines the method and calculation. It may refer to HPLC area percentage, an assay against a reference standard, or an internal calculation on an as-is or dry basis. Two suppliers can therefore show the same number while measuring different things.

For this ingredient, the most useful COA is not necessarily the one with the largest assay number. A batch-specific document with a clear method, identity test, related-substance limits and traceable lot information provides a stronger basis for qualification than a one-page typical analysis sheet.

Look Specifically for Esterification-Related Evidence

Kojic Dipalmitate is an esterified derivative of kojic acid. That chemical change affects how the material behaves in a formulation, so the buyer should ask whether the analytical package can distinguish the intended dipalmitate from free kojic acid, mono-palmitate, unreacted palmitic acid and other process-related peaks. The supplier does not need to disclose proprietary process details, but the finished material still needs an identity and impurity-control story.

• Ask whether the assay is reported against a Kojic Dipalmitate reference standard and request the chromatographic method or a representative chromatogram.
• Ask whether free kojic acid is separately tested or controlled. Do not assume that 99% means zero free kojic acid.
• Ask for the material's appearance, melting or softening range if used in the supplier specification, and storage conditions.
• Confirm whether the powder is neat or contains a carrier, processing aid, antioxidant or other undisclosed component.
• Match the sample label, COA lot number, package label and quotation product code before ranking the offer.

This is also where formula claims should be kept separate from identity claims. A supplier may show a brightening or antioxidant test for a finished product. That can be useful for product development, but it does not establish that the raw powder meets a particular purity or impurity specification.

Plan the Formulation Check Around the Oil Phase

Compared with kojic acid, the dipalmitate derivative is used in more lipophilic formulation contexts. A 2015 study examined Kojic Dipalmitate in a water-in-oil-in-water multiple-emulsion system, while a 2023 study evaluated KDP-loaded nanoemulsions with rosehip oil. Those studies show how the ingredient can be investigated inside a carrier system; they do not guarantee identical behavior in every cream, serum, balm or anhydrous oil.[3,4]

Before committing to a larger lot, run a small bench screen in the actual vehicle. Record the material lot, addition order, temperature, mixing time, concentration, appearance and any sediment or crystallization. Check the sample again after a defined hold period and after the formula has experienced the intended pH, heat, light and freeze-thaw conditions. If the supplier gives a solubility statement, ask what solvent, temperature, concentration and observation time were used.

Do not write oil soluble as if it were a complete performance specification. A material can disperse in one oil blend and crystallize in another. The useful purchasing question is: does this exact lot remain physically acceptable at our target concentration in our base?

What the Published Evidence Does—and Does Not—Show

The 2022 ethosomal-gel paper and the 2023 nanoemulsion paper are formulation studies. They report results for specified systems, concentrations, preparation methods and test models. Their value for a buyer is to show that formulation design matters and that KDP can be evaluated in delivery systems. Their results should not be rewritten as universal claims about every commercial powder.[5,6]

The 2022 paper compared a KDP-loaded nanosized ethosomal gel in vitro and in vivo. The 2023 paper reported a KDP nanoemulsion containing rosehip oil, including antioxidant and depigmenting measurements in the tested model. Neither paper removes the need for raw-material identity, assay, stability or compatibility checks. Nor do they justify calling a marketplace product clinically proven unless the exact commercial material and the full study are linked.

A responsible product page can therefore say that published formulation research exists, while keeping the commercial conclusion conditional: finished-product performance depends on the identity and quality of the raw material, its concentration, the vehicle, processing, stability and the study design.

A Practical RFQ for the First Supplier Round

• Exact product name, INCI name, CAS number, molecular formula, molecular weight and supplier product code.
• Neat powder or blended system; if blended, every carrier and the active-equivalent percentage.
• Assay method, reference standard, acceptance range and whether the result is as-is or dry basis.
• Identity data that distinguishes KDP from free kojic acid, mono-esters and related substances.
• Batch-specific COA with lot number, manufacture date, retest or expiry date, and authorized sign-off.
• TDS and SDS covering appearance, storage, packaging, handling and any stated solubility or compatibility information.
• MOQ, sample availability, package size, lead time, country of manufacture and change-notification policy.
• Microbial, heavy-metal, residual-solvent and regional compliance documents relevant to the intended market.

Keep the questions identical across suppliers. Otherwise, one supplier may quote a neat 99% powder while another quotes a lower-cost carrier system, and the comparison will look more precise than it really is.

Current Sourcing Leads

The sourcing options below are listed for review. They are commercial discovery links, not technical approval. Product information and price can change, so match the live page to the sample and current COA before publishing a procurement recommendation.

Use Supplier Age as a Signal, Not a Substitute for Evidence

Alibaba profile age can help with continuity screening, but it is not proof of factory ownership, quality or current production capability. A supplier with seven or eight years on the platform may still outsource the material or show limited testing infrastructure. A younger supplier may have a credible technical partner or a useful sample package. Treat age as one weighted signal and give more weight to lot traceability, document consistency, response quality, sample performance and the ability to explain analytical fields.

For a first round, prefer offers where the product page, supplier profile, sample route and document package point to the same commercial material. If the page says HPLC, COA, MSDS or TDS are available, request the current versions for the exact grade rather than relying on the page badge.

Final Decision Rule

Approve a Kojic Dipalmitate offer only when the supplier can connect the marketplace listing, sample, product code, COA lot, identity data and formulation-relevant physical information. Suspend the offer when purity has no defined method, the CAS or formula conflicts are ignored, the sample cannot be tied to the COA, or a finished-product study is presented as proof of neat-powder equivalence. A lower headline percentage with a complete, auditable file may be a better buying decision than a 99% offer whose identity and assay basis remain unclear.

References

1. National Center for Biotechnology Information. PubChem Compound Summary: Kojic acid dipalmitate, CID 15801174. https://pubchem.ncbi.nlm.nih.gov/compound/15801174
2. Tokyo Chemical Industry Co., Ltd. Kojic Acid Dipalmitate, product K0050. https://www.tcichemicals.com/CA/en/p/K0050
3. Tanveer N, et al. Whitening effect of kojic acid dipalmitate loaded nanosized ethosomal gel for the treatment of hyperpigmentation. Drug Development and Industrial Pharmacy. 2022. https://pubmed.ncbi.nlm.nih.gov/36156360/
4. Zilles JC, et al. Nanoemulsion Containing Kojic Dipalmitate and Rosehip Oil: A Promising Formulation to Treat Melasma. Pharmaceutics. 2023. https://pubmed.ncbi.nlm.nih.gov/36839792/
5. Borges VR, et al. Structural characterization and in vitro antioxidant activity of kojic dipalmitate loaded W/O/W multiple emulsions. Journal of Nanobiotechnology. 2015. https://pubmed.ncbi.nlm.nih.gov/25785265/
6. Madan V, et al. Comparative Stability of Two Anti-hyperpigmentation Agents: Kojic Acid and Its Di-Palmitate Ester. Drug Research. 2014. https://pubmed.ncbi.nlm.nih.gov/35620332/
7. A rapid and reliable size-exclusion chromatographic method for determination of kojic dipalmitate in skin-whitening cosmetic products. Journal of Chromatography B. 2008. https://pubmed.ncbi.nlm.nih.gov/18371899/